Altamira Therapeutics Ltd. (CYTOF)
OTCMKTS · Delayed Price · Currency is USD
0.1100
-0.0150 (-11.99%)
At close: Jan 16, 2026
Altamira Therapeutics Market Cap
Altamira Therapeutics has a market cap or net worth of $628.7 thousand as of January 16, 2026. Its market cap has decreased by -63.03% in one year.
Market Cap
628.70K
Enterprise Value
1.41M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.11
Market Cap Chart
Since August 8, 2014, Altamira Therapeutics's market cap has decreased from 171.70M to 628.70K, a decrease of -99.63%. That is a compound annual growth rate of -38.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 714.38K | 35.14% |
| Dec 31, 2025 | 528.62K | 40.64% |
| Dec 31, 2024 | 375.87K | -72.84% |
| Dec 29, 2023 | 1.38M | -75.59% |
| Dec 30, 2022 | 5.67M | -78.93% |
| Dec 31, 2021 | 26.91M | -10.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 807.56M |
| Glass House Brands | 742.36M |
| Elite Pharmaceuticals | 511.53M |
| Northwest Biotherapeutics | 447.86M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 335.01M |
| Silence Therapeutics | 277.26M |